IRMD
Companies
NASDAQ
Iridium Corporation
Health Care
$57.96
+$3.31 (+6.05%)
Price Chart
Overview
About IRMD
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Market Cap
$538.2M
Volume
1.8M
Avg. Volume
2.0M
P/E Ratio
30.45143
Dividend Yield
0.64%
Employees
128.0
Company Information
Latest News for IRMD
Risk & Correlation Analysis
Market Correlation
0.63
Low Correlation
Volatility
Medium (0.33)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IRMD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$538.2M
Volume1.8M
P/E Ratio30.45
Dividend Yield0.64%
Important Dates
Next Dividend
Next Earnings
May 5, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025